Category: by subject

Doing the right thing: Researchers retract quorum sensing paper after public process

Pamela Ronald, via UC Davis
Pamela Ronald, via UC Davis

We’ll say it again: We like being able to point out when researchers stand up and do the right thing, even at personal cost.

In December 2011, Pamela C. Ronald, of the University of California, Davis, and colleagues published a paper in PLOS ONE,”Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium.” Such quorum sensing research is a “hot topic” right now, so not surprisingly the paper caught the attention of other scientists, and the media, including the Western Farm Press. The study has been cited eight times, according to Thomson Scientific’s Web of Knowledge.

One of those scientists who took notice was Ronald’s UC Davis colleague Jonathan Eisen, who posted about the paper on his blog. That was on January 9, 2012. But if you go to that post today, you’ll see that Eisen struck through most of it, and added this comment: Continue reading Doing the right thing: Researchers retract quorum sensing paper after public process

Real problems with retracted shame and money paper revealed

sjdmLast month, we reported on a retraction in Judgment and Decision Making that said “problems were discovered with the data.” At the time, corresponding author Wen-Bin Chiou, of National Sun Yat-sen University in Taiwan, told us that a research assistant who had since left the lab hadn’t kept questionnaires used in the research, making replication impossible.

But it turns out that wasn’t the whole story of “Shame for money: Shame enhances the incentive value of economic resources,” to put it charitably. We’ve now heard from people familiar with the case and can provide a fuller account.

The problems with the paper, according to our source, Continue reading Real problems with retracted shame and money paper revealed

What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

a&amisconductcoverCHICAGO — Almost two years after editors at 18 journals agreed in March 2011 to retract 88 of former retraction record holder Joachim Boldt’s papers, 10% of them hadn’t been retracted.

That’s what Nadia Elia, Liz Wager, and Martin Tramer reported here Sunday in an abstract at the Seventh International Congress on Peer Review and Biomedical Publication. Elia and Tramer are editors at the European Journal of Anaesthesiology, while Wager is former chair of the Committee on Publication Ethics (COPE).

As of January 2013, nine of the papers hadn’t been retracted, Tramer said, while only five — all in one journal — had completely followed COPE guidelines, with adequate retraction notices, made freely available, along with  PDFs properly marked “Retracted.” From the abstract (see page 18): Continue reading What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

Papers on potential cancer drugs retracted for image manipulation

ccr 9-13A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation.

The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab” say the same thing: Continue reading Papers on potential cancer drugs retracted for image manipulation

Lancet retracts Jikei Heart Study of valsartan following investigation

logo_lancetThe Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.

Continue reading Lancet retracts Jikei Heart Study of valsartan following investigation

Too much skin in the game, as duplications force retraction of psoriasis paper

actadermA group of dermatology researchers from Egypt who passed around a psoriasis paper like a bottle of sunscreen at the beach have been burned (sorry) by a journal that caught them in the act.

Acta Dermatovenerologica Alpina, Pannonica et Adriatica is retracting the 2009 article “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt” after discovering that they were far from the first publication to print the paper.

Here’s the retraction notice (it’s a pdf): Continue reading Too much skin in the game, as duplications force retraction of psoriasis paper

When two words colloid: “copied and manipulated” figures prompt retraction of nanoparticle paper

colloids and surfaces bThe journal Colloids and Surfaces B: Biointerfaces has retracted a 2011 paper by a group of researchers in India who misappropriated — and then manhandled — a pair of images from a previously published article by other scientists.

The paper, “Synthesis and characterization of chitosan and grape polyphenols stabilized palladium nanoparticles and their antibacterial activity,” was written by authors from various institutions in Tamil Nadu, and appeared online in December 2011 and in print the following April. It has been cited three times, according to Thomson Scientific’s Web of Knowledge.

Here’s the abstract: Continue reading When two words colloid: “copied and manipulated” figures prompt retraction of nanoparticle paper

Math paper retracted because it “contains some ethical problems”

inequalThe Journal of of Inequalities and Applications has retracted a paper for unspecified “ethical problems.”

Here’s the notice for “Strong Limiting Behavior in Binary Search Trees:” Continue reading Math paper retracted because it “contains some ethical problems”

Chemistry papers retracted for “lack of objectivity:” The authors did their own peer review

synthreactSynthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry is retracting three articles for duplication — redundancy the authors, chemical engineers at Islamic Azad University, in Shahreza, Iran, appear to have gotten around by reviewing their own manuscripts. But, if they did say so themselves, those papers were really something!

Here’s the retraction notice for two of the papers, both of which appeared in 2012 and which were cited seven times and once, respectively, according to Thomson Scientific’s Web of Knowledge:
Continue reading Chemistry papers retracted for “lack of objectivity:” The authors did their own peer review

Frontiers papers on GMO debate, diabetes retracted for improperly cited text

frontiers plantThe author of a review article on diabetes has been forced to retract the paper after it emerged that he failed to properly credit some of the text — an omission we generally associate with the word plagiarism.

The article, “Colonic flora, probiotics, obesity and diabetes,” was written by Paul Marik, of Eastern Virginia Medical School, and appeared in July 2012 in Frontiers in Endocrinology. It has been cited once, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice:

Continue reading Frontiers papers on GMO debate, diabetes retracted for improperly cited text